Understanding New Options for CLL: Accessing the Best Care for You or a Loved One

February 18, 2017



An audience of CLL patients and their caregivers joined us at a recent town meeting at The University of Texas MD Anderson Cancer Center to hear about emerging and current therapies in CLL, effective tools for treatment planning and monitoring, and support resources.

We are also planning events in other cities. If you haven’t already, please sign up for email updates, so we can alert you when important and inspiring videos become available and when upcoming town meetings are scheduled. 

 

Patient Folder

 

 

 

 


CAR T-Cell Therapy: An Overview

What is a CAR and what role does CAR T-cell therapy play in targeted therapy? Experts Drs. Nicole Lamanna and Michael Keating explain.

Published:

Published:

How Does Venetoclax Work to Treat CLL?

Stay informed on CLL therapies. How does venetoclax work? With Drs. Nicole Lamanna and Michael Keating.

Published:

Understanding the Difference Between SLL and CLL

Learn the difference between CLL and SLL from experts Drs. Michael Keating and Nicole Lamanna.

Published:

Allen Melançon: Why Should Patients Consider a Clinical Trial?

Meet CLL patient and patient advocate, Allen Melançon, as he shares his story and clinical trial experiences.

Published:

Jeff Folloder: Why Should Patients Give Back to the Cancer Community?

Jeff Folloder, a CLL patient advocate, explains why he gives back to the cancer community.

Published:

How Can Integrative Medicine Help With Fatigue?

How can integrative medicine help with fatigue? Dr. Wenli Liu of MD Anderson Cancer Center explains.

Published:

Understanding New Options for CLL: Session 2 Replay

Watch the replay of session two of our “Understanding New Options for CLL” town meeting, featuring leading experts, Dr. Michael Keating and Dr. Nicole Lamanna.

Published:

Understanding New Options for CLL: Session 1 Replay

Watch the replay of session one of our “Understanding New Options for CLL” town meeting, featuring leading experts, Dr. Michael Keating and Dr. Nicole Lamanna.

Published:

Host & Guests
Host

Host, Patient Power Co-Founder, Two-Time Cancer Survivor and Patient Advocate


Guests

Associate Clinical Professor of Medicine

Columbia University Medical Center


Associate Professor, Integrative Medicine Program


Patient Advocate



This town meeting was provided by CLL Global Research Foundation, which received support from AbbVie Inc., Genentech Inc., Gilead Sciences, Pharmacyclics, Inc., Teva Pharmaceuticals and TG Therapeutics. It was produced by Patient Power in partnership with The University of Texas MD Anderson Cancer Center.


Patient Power
CLL Global Research Foundation
The University of Texas MD Anderson Cancer Center
Advertisement
Join Our Community Register for Events Read Our Latest Blog
Advertisement

Page last updated on April 5, 2018